Numerous investigations increasingly indicate the significance of microRNA (miRNA) in human diseases. Hence, unearthing associations between miRNA and diseases can contribute to precise diagnosis and efficacious remediation of medical conditions. The detection of miRNA-disease linkages via computational techniques utilizing biological information has emerged as a cost-effective and highly efficient approach. Here, we introduced a computational framework named ReHoGCNES, designed for prospective miRNA-disease association prediction (ReHoGCNES-MDA). This method constructs homogenous graph convolutional network with regular graph structure (ReHoGCN) encompassing disease similarity network, miRNA similarity network and known MDA network and then was tested on four experimental tasks. A random edge sampler strategy was utilized to expedite processes and diminish training complexity. Experimental results demonstrate that the proposed ReHoGCNES-MDA method outperforms both homogenous graph convolutional network and heterogeneous graph convolutional network with non-regular graph structure in all four tasks, which implicitly reveals steadily degree distribution of a graph does play an important role in enhancement of model performance. Besides, ReHoGCNES-MDA is superior to several machine learning algorithms and state-of-the-art methods on the MDA prediction. Furthermore, three case studies were conducted to further demonstrate the predictive ability of ReHoGCNES. Consequently, 93.3% (breast neoplasms), 90% (prostate neoplasms) and 93.3% (prostate neoplasms) of the top 30 forecasted miRNAs were validated by public databases. Hence, ReHoGCNES-MDA might serve as a dependable and beneficial model for predicting possible MDAs.
Drug-target interactions play a crucial role in target-based drug discovery and exploitation. Computational prediction of DTIs has become a popular alternative strategy to the experimental methods for identification of DTIs of which are both time and resource consuming. However, the performances of the current DTIs prediction approaches suffer from a problem of low precision and high false positive rate. In this study, we aimed to develop a novel DTIs prediction method, named DTI-CDF, for improving the prediction precision based on a cascade deep forest model which integrates hybrid features, including multiple similarity-based features extracted from the heterogeneous graph, fingerprints of drugs, and evolution information of target protein sequences. In the experiments, we built five replicates of 10 fold cross-validations under three different experimental settings of data sets, namely, corresponding DTIs values of certain drugs ( SD ), targets ( ST ), or drug-target pairs ( SP ) in the training set are missed, but existed in the test set. The experimental results show that our proposed approach DTI-CDF achieved significantly higher performance than the state-of-the-art methods.
10 December 2025 in IEEE Journal of Biomedical and Health Informatics
Accurate drug-target interaction prediction is vital for drug discovery and optimization. Traditional experimental methods, while effective, are time-intensive and costly. HyperGCN-DTI, a novel framework that explicitly advances beyond existing models such as CHL-DTI and HHDTI by leveraging hypergraph neural networks with a multimodal feature fusion strategy. While exsiting methods primarily focuses on low-order graph representations and fixed heterogeneous network structures, HyperGCN-DTI incorporates richer multimodal fused features including embeddings from pretrained language models and diverse biological networks and build robust hypergraphs that capture high-order multi-entity relationships within drug-target pairs. This dual-channel architecture effectively captures both local topological connections and higher-order structural dependencies. HyperGCN-DTI outperforms state-of-the-art DTI prediction models across multiple datasets and remains robust under imbalanced and large-scale real-world datasets, demonstrating its superior predictive power. The model demonstrates significant improvements when using multimodal features and hypergraph-based message passing, with sensitivity analysis confirming stability across hyperparameter variations. Top-ranked predictions are validated through biomedical literature and molecular docking, underscoring the reliability and practical relevance of our approach. HyperGCN-DTI is the first DTI prediction model to jointly integrate such a wide range of heterogeneous information sources with hypergraph representation, significantly enhancing accuracy and robustness, particularly in sparse or noisy settings. The proposed model offers a powerful and generalizable tool for accelerating drug development and target identification.
Messenger RNA (mRNA) vaccines offer promising therapeutics for combating various diseases, yet their inherent chemical instability hampers their long-term efficacy. Although several methods have been developed to predict mRNA degradation, they exhibit limited accuracy and lack the capability for rational sequence optimization. Here, we propose RNASTOP, a novel framework integrating deep learning with heuristic search to simultaneously predict and optimize mRNA chemical stability. RNASTOP achieves a 13% accuracy improvement over the top-performing model on the Stanford OpenVaccine competition dataset and demonstrates robust generalization in predicting full-length mRNA degradation. Applied to mRNA codon optimization, RNASTOP reduces the minimum free energy of the Varicella-Zoster Virus vaccine sequence by 75.73% while maintaining high translation efficiency. Overall, RNASTOP serves as a powerful tool for predicting and optimizing mRNA chemical stability, poised to expedite the development of mRNA therapeutics. The source code of RNASTOP can be accessed at https://github.com/xlab-BioAI/RNASTOP .